Acquisition of H2B by Novacap


We are pleased to announce the acquisition of H2B by the French group Novacap, worldwide player in the chemical and pharmaceutical industry.

“Novacap will support ID bio and H2B to accelerate their development leveraging the two companies’ market approaches and recognised expertise. The complementarities between our two groups open up outstanding prospects for the future”, said Jean Pierre Picot, Founding President of H2B and ID bio.

Complete press release available here.

Go back

This website uses cookies, by continuing to browse this website you agree to our cookie policy.